Cambridge Quarterly of Healthcare Ethics 18 (1):78 (2009)
In an earlier piece in these pages, I described the health effects of the still massive problem of global poverty: The poor worldwide face greater environmental hazards than the rest of us, from contaminated water, filth, pollution, worms, and insects. They are exposed to greater dangers from people around them, through traffic, crime, communicable diseases, sexual violence, and potential exploitation by the more affluent. They lack means to protect themselves and their families against such hazards, through clean water, nutritious food, satisfactory hygiene, necessary rest, adequate clothing, and safe shelter. They lack the means to enforce their legal rights or to press for political reform
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
References found in this work BETA
No references found.
Citations of this work BETA
Access to Life-Saving Medicines and Intellectual Property Rights: An Ethical Assessment.Doris Schroeder & Peter Singer - 2011 - Cambridge Quarterly of Healthcare Ethics 20 (2):279-289.
Developing Medicines in Line with Global Public Health Needs: The Role of the World Health Organization.Tikki Pang - 2011 - Cambridge Quarterly of Healthcare Ethics 20 (2):290-297.
Feminist Resources for Biomedical Research: Lessons From the HPV Vaccines.Melo-martín Inmaculada de & Intemann Kristen - 2011 - Hypatia 26 (1):79 - 101.
Should Patents for Antiretrovirals Be Waived in the Developing World? Annual Varsity Medical Debate - London, 21 January 2011.Fenella Corrick, Robert Watson & Sanjay Budhdeo - 2011 - Philosophy, Ethics, and Humanities in Medicine 6 (1):1-6.
Similar books and articles
Incentivizing Access and Innovation for Essential Medicines: A Survey of the Problem and Proposed Solutions.Michael Ravvin - 2008 - Public Health Ethics 1 (2):110-123.
The Health Impact Fund: A Useful Supplement to the Patent System?Aidan Hollis - 2008 - Public Health Ethics 1 (2):124-133.
Global Health Impact: A Basis for Labeling and Licensing Campaigns?Nicole Hassoun - 2012 - Developing World Bioethics 12 (3):121-134.
Common Health Policy Interests and the Shaping of Global Pharmaceutical Policies.Meri Koivusalo - 2010 - Ethics and International Affairs 24 (4):395-414.
Human Rights Responsibilities of Pharmaceutical Companies in Relation to Access to Medicines.Joo-Young Lee & Paul Hunt - 2012 - Journal of Law, Medicine & Ethics 40 (2):220-233.
A Critique in Need of Critique.M. Peterson, A. Hollis & T. Pogge - 2010 - Public Health Ethics 3 (2):178-185.
The Health Impact Fund and its Justification by Appeal to Human Rights.Thomas Pogge - 2009 - Journal of Social Philosophy 40 (4):542-569.
Responsibilities for Global Health: The Efficiency of the Health Impact Fund?V. Paivansalo - 2008 - Public Health Ethics 2 (1):100-104.
Pharmaceutical Innovation and the Burden of Disease in Developing and Developed Countries.Frank R. Lichtenberg - 2005 - Journal of Medicine and Philosophy 30 (6):663 – 690.
Pharmaceutical Advertisements: How They Deceive Patients. [REVIEW]Ashish Chandra & Gary A. Holt - 1999 - Journal of Business Ethics 18 (4):359 - 366.
Three Proposals for Rewarding Novel Health Technologies Benefiting People Living in Poverty. A Comparative Analysis of Prize Funds, Health Impact Funds and a Cost-Effectiveness/Competitive Tender Treaty.Thomas Alured Faunce & Hitoshi Nasu - 2008 - Public Health Ethics 1 (2):146-153.
A Critique of the Innovation Argument Against a National Health Program.Alex Rajczi - 2007 - Bioethics 21 (6):316–323.
The Constant Gardener Revisited: The Effect Ofsocial Blackmail on the Marketing Concept,Innovation, and Entrepreneurship. [REVIEW]Morgan P. Miles, Linda S. Munilla & Jeffrey G. Covin - 2002 - Journal of Business Ethics 41 (3):287 - 295.
Added to index2010-08-24
Total downloads27 ( #188,224 of 2,163,972 )
Recent downloads (6 months)1 ( #348,100 of 2,163,972 )
How can I increase my downloads?